Skip to main content

Cornerstone Therapeutics, Inc. (NASDAQ:CRTX) Investor Files Lawsuit In Efort To Halt The Proposed Acquisition

  • If you purchased shares of the Cornerstone Therapeutics, Inc. (NASDAQ:CRTX) and currently hold any of those NASDAQ:CRTX shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Lawsuit Overview

September 23, 2013 (Shareholders Foundation) - An investor, who currently hold shares of Cornerstone Therapeutics, Inc. (NASDAQ:CRTX) filed a lawsuit in effort to halt the proposed takeover of Cornerstone Therapeutics, Inc. by Chiesi Farmaceutici SpA for $9.50 per NASDAQ:CRTX share. The plaintiff alleges that the defendants breached their fiduciary duties owed to NASDAQ:CRTX stockhol...



You must register (for free) or login to view the entire case.